{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T01:53:46Z","timestamp":1792547626617,"version":"4.5.0"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T00:00:00Z","timestamp":1665532800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Atopic dermatitis (AD) is a chronic and recurrent skin disease. At present, there is a lack of sufficiently effective and safe medicines that can be used for a prolonged time and reduce the recurrence of AD. The Gu-Ben-Hua-Shi (AESS) formula has been used for many years with a good clinical effect on AD but its specific treatment mechanism is unknown.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> The main components of AESS were analyzed using ultra-high performance liquid chromatography (UPLC). The composition of AESS compounds in the serum from rats was analyzed using ultra-high performance liquid chromatography-mass spectrometry. An AD mouse model was constructed using 2,4-dinitrofluorobenzene stimulation in Balb\/C mice and the effect on the reduction of skin lesions and Th1\/Th2\/Th17\/Treg balance after AESS administration were measured. The effects of AESS serum on the proliferation and apoptosis of keratinocyte cell line HaCaT and adhesion of HaCaT to human monocyte cell line THP-1 were detected in an IFN-\u03b3\/TNF-\u03b1 stimulated AD-like inflammatory cell model. The effects of Yes-associated protein (YAP) expression on the therapeutic effect and a related signaling pathway were also investigated.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> In total, 10 components were confirmed using UPLC, namely five organic acids, three flavonoids, and two chromogenic ketones. Additionally, the similarity of the three batches of samples (S1\u20133) was above 0.98, indicating that the formula samples have good uniformity. These 10 compounds were also detected in rat serum, suggesting that they are absorbed into rat blood as prototype components. Furthermore, AESS effectively reduced the skin lesions in the AD mouse model, regulated the Th1\/Th2\/Th17\/Treg imbalance, improved the proliferation ability of the AD-like cell model, and inhibited HaCaT apoptosis and adhesion to THP-1 cells. It also reduced the expression of YAP in Th17 and Treg cells of the mouse spleen and increased YAP expression in the skin. The change in YAP expression in keratinocytes weakened the curative effect of AESS, and AESS exerted its effects through the NF-\u03baB signaling pathway.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> AESS may play a role in the treatment of AD by affecting the expression of YAP. These findings can be used to promote its use as an alternative medication for prolonged use with fewer side effects.<\/jats:p>","DOI":"10.3389\/fphar.2022.929580","type":"journal-article","created":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T08:12:22Z","timestamp":1665562342000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Therapeutic effect of chinese herbal medicine gu-ben-hua-shi (AESS) formula on atopic dermatitis through regulation of yes-associated protein"],"prefix":"10.3389","volume":"13","author":[{"given":"Jinjing","family":"Jia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luyao","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siqi","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiyue","family":"Ping","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiumei","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dacan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,10,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e612","DOI":"10.1111\/jdv.17210","article-title":"Dupilumab and conjunctivitis: A case-series of twenty patients","volume":"35","author":"Calabrese","year":"2021","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"102000","DOI":"10.1016\/j.pupt.2021.102000","article-title":"Myricetin inhibits TNF-\u03b1-induced inflammation in A549 cells via the SIRT1\/NF-\u03baB pathway","volume":"65","author":"Chen","year":"2020","journal-title":"Pulm. Pharmacol. Ther."},{"key":"B3","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3390\/children6090103","article-title":"Biologic treatment options for pediatric psoriasis and atopic dermatitis","volume":"6","author":"Cline","year":"2019","journal-title":"Children"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1111\/bjd.16156","article-title":"Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: A placebo-controlled, randomized phase III clinical trial (liberty AD caf\u00e9)","volume":"178","author":"de Bruin-Weller","year":"2018","journal-title":"Br. J. Dermatol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.jaci.2016.06.002","article-title":"Multifactorial skin barrier deficiency and atopic dermatitis: Essential topics to prevent the atopic march","volume":"138","author":"Egawa","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.intimp.2017.01.023","article-title":"Formula PSORI-CM01 inhibits the inflammatory cytokine and chemokine release in keratinocytes via NF-\u03baB expression","volume":"44","author":"Han","year":"2017","journal-title":"Int. Immunopharmacol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.intimp.2018.06.046","article-title":"Regulatory effects of chrysophanol, a bioactive compound of AST2017-01 in a mouse model of 2, 4-dinitrofluorobenzene-induced atopic dermatitis","volume":"62","author":"Han","year":"2018","journal-title":"Int. Immunopharmacol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.jdermsci.2010.10.013","article-title":"Decrease in circulating Th17 cells correlates with increased levels of CCL17, IgE and eosinophils in atopic dermatitis","volume":"61","author":"Hayashida","year":"2011","journal-title":"J. Dermatol. Sci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1159\/000479528","article-title":"Sea buckthorn (Hippopha\u00eb rhamnoides L.) oil improves atopic dermatitis-like skin lesions via inhibition of NF-\u03baB and STAT1 activation","volume":"30","author":"Hou","year":"2017","journal-title":"Skin. Pharmacol. Physiol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.3969\/j.issn.1009-2501.2004.09.026","article-title":"Equivalent dose conversion between animals and between animals and human body in pharmacological test","volume":"9","author":"Huang","year":"2004","journal-title":"Chin. Clin. Pharmacol. Ther."},{"key":"B11","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.jdermsci.2020.12.004","article-title":"Role of YAP-related T cell imbalance and epidermal keratinocyte dysfunction in the pathogenesis of atopic dermatitis","volume":"101","author":"Jia","year":"2021","journal-title":"J. Dermatol. Sci."},{"key":"B12","article-title":"Study on the regulation of T cell subgroup balance in patients with eczema by Gu-Ben-Hua-Shi Formula","author":"Jia","year":"2022","journal-title":"Chin. J. Dermatovenreo Integr. Tradit. West Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1111\/all.12982","article-title":"Atopic dermatitis, atopic eczema, or eczema? A systematic review, meta-analysis, and recommendation for uniform use of \u2018atopic dermatitis","volume":"71","author":"Kantor","year":"2016","journal-title":"Allergy"},{"key":"B14","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.intimp.2013.01.005","article-title":"Mechanism underlying the effect of combined therapy using glucosamine and low-dose cyclosporine A on the development of atopic dermatitis-like skin lesions in NC\/Nga mice","volume":"15","author":"Kim","year":"2013","journal-title":"Int. Immunopharmacol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.jaad.2016.05.028","article-title":"Persistence of atopic dermatitis (AD): A systematic review and meta-analysis","volume":"75","author":"Kim","year":"2016","journal-title":"J. Am. Acad. Dermatol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1038\/jid.2008.111","article-title":"Possible pathogenic role of Th17 cells for atopic dermatitis","volume":"128","author":"Koga","year":"2008","journal-title":"J. Invest. Dermatol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/S0140-6736(20)31286-1","article-title":"Atopic dermatitis","volume":"396","author":"Langan","year":"2020","journal-title":"Lancet"},{"key":"B18","doi-asserted-by":"publisher","first-page":"742","DOI":"10.3389\/fphar.2019.00742","article-title":"Soshiho-tang, a traditional herbal medicine, alleviates atopic dermatitis symptoms via regulation of inflammatory mediators","volume":"10","author":"Lee","year":"2019","journal-title":"Front. Pharmacol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"248","DOI":"10.2174\/187221312802652802","article-title":"Atopic dermatitis and cytokines: The immunoregulatory and therapeutic implications of cytokines in atopic dermatitis--part II: Negative regulation and cytokine therapy in atopic dermatitis.","volume":"6","author":"Lee","year":"2012","journal-title":"Recent Pat. Inflamm. Allergy Drug Discov."},{"key":"B20","volume-title":"Contemporary distinguished TCM dermatologists series - dacan chen","author":"Liu","year":"2019"},{"key":"B21","doi-asserted-by":"publisher","first-page":"eaat1604","DOI":"10.1126\/sciimmunol.aat1604","article-title":"Type 2 immunity: Expanding our view","volume":"3","author":"Lloyd","year":"2018","journal-title":"Sci. Immunol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1111\/jdv.12288","article-title":"The Imbalance of Th17 cells and CD4(+) CD25(high) Foxp3(+) Treg cells in patients with atopic dermatitis","volume":"28","author":"Ma","year":"2014","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"12801","DOI":"10.21037\/apm-21-3590","article-title":"Increased expression of T helper 17 cells and interleukin-17 in atopic dermatitis: A systematic review and meta-analysis","volume":"10","author":"Mao","year":"2021","journal-title":"Ann. Palliat. Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"3847","DOI":"10.3390\/cancers12123847","article-title":"The YAP\/TEAD axis as a new therapeutic target in osteosarcoma: Effect of verteporfin and CA3 on primary tumor growth","volume":"12","author":"Morice","year":"2020","journal-title":"Cancers"},{"key":"B25","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/nrc3876","article-title":"The emerging roles of YAP and TAZ in cancer","volume":"15","author":"Moroishi","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1016\/j.jaci.2015.08.015","article-title":"The Asian atopic dermatitis phenotype combines features of atopic dermatitis and psoriasis with increased TH17 polarization","volume":"136","author":"Noda","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s00428-007-0558-5","article-title":"Increased expression of monocarboxylate transporters 1, 2, and 4 in colorectal carcinomas","volume":"452","author":"Pinheiro","year":"2008","journal-title":"Virchows Arch."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.7150\/ijbs.65973","article-title":"Melatonin reverses tumor necrosis factor-alpha-induced metabolic disturbance of human nucleus pulposus cells via MTNR1B\/G\u03b1i2\/YAP signaling","volume":"18","author":"Qiu","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1111\/all.12712","article-title":"Foxp3(+) regulatory T cells are expanded in severe atopic dermatitis patients","volume":"70","author":"Roesner","year":"2015","journal-title":"Allergy"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1038\/jid.2011.446","article-title":"IL-33 and ST2 in atopic dermatitis: Expression profiles and modulation by triggering factors","volume":"132","author":"Savinko","year":"2012","journal-title":"J. Invest. Dermatol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.3390\/ijms21041314","article-title":"The role of Th17-related cytokines in atopic dermatitis","volume":"21","author":"Sugaya","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B32","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1002\/jat.4065","article-title":"Role of the Hippo-YAP\/NF-\u03baB signaling pathway crosstalk in regulating biological behaviors of macrophages under titanium ion exposure","volume":"41","author":"Tang","year":"2021","journal-title":"J. Appl. Toxicol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1186\/s12906-016-1234-6","article-title":"Formula PSORI-CM01 eliminates psoriasis by inhibiting the expression of keratinocyte cyclin B2","volume":"16","author":"Wei","year":"2016","journal-title":"BMC Complement. Altern. Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1111\/jdv.14888","article-title":"Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: Part II","volume":"32","author":"Wollenberg","year":"2018","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"11175","DOI":"10.1038\/s41598-021-90105-w","article-title":"Transcriptomic analysis of atopic dermatitis in African Americans is characterized by Th2\/Th17-centered cutaneous immune activation","volume":"11","author":"Wongvibulsin","year":"2021","journal-title":"Sci. Rep."},{"key":"B36","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3969\/j.issn.1005-5304.2014.07.030","article-title":"Experience of professor Chen Dacan applying the method of Sanshusanteng medicinal couple to treat intractable skin diseases","volume":"21","author":"Wu","year":"2014","journal-title":"Chin. J. Inf. Tradit. Chin. Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1097\/JD9.0000000000000071","article-title":"Effects of honokiol on activation of transient receptor potential channel V1 and secretion of thymic stromal Lymphopoietin in HaCaT keratinocytes","volume":"3","author":"Xie","year":"2020","journal-title":"Int. J. Dermatol. Venereol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"110142","DOI":"10.1016\/j.biopha.2020.110142","article-title":"The formulae and biologically active ingredients of Chinese herbal medicines for the treatment of atopic dermatitis","volume":"127","author":"Yan","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"B39","doi-asserted-by":"publisher","first-page":"4698","DOI":"10.1002\/jcp.29348","article-title":"YAP1 inhibits the induction of TNF-\u03b1-stimulated bone-resorbing mediators by suppressing the NF-\u03baB signaling pathway in MC3T3-E1 cells","volume":"235","author":"Yang","year":"2020","journal-title":"J. Cell. Physiol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"7939","DOI":"10.1111\/jcmm.15426","article-title":"Yes-associated protein promotes tumour necrosis factor \u03b1-treated cementoblast mineralization partly by inactivating NF-\u03baB pathway","volume":"24","author":"Zhang","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3969\/J.ISSN.1671-6027.2010.05.032","article-title":"Conversion of dosage among different experimental animals","volume":"5","author":"Zhao","year":"2010","journal-title":"Chin J Anim Husb Vet Med"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.929580\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T08:12:29Z","timestamp":1665562349000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.929580\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,12]]},"references-count":41,"alternative-id":["10.3389\/fphar.2022.929580"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.929580","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,12]]},"article-number":"929580"}}